Contemporary assessment of stent strut coverage by OCT.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 22535230)

Published in Int J Cardiovasc Imaging on April 26, 2012

Authors

Guilherme F Attizzani1, Hiram G Bezerra

Author Affiliations

1: Harrington Heart and Vascular Institute, University Hospitals Case Medical Center, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106, USA.

Articles cited by this

Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation (2007) 5.05

Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol (2005) 3.17

Intracoronary optical coherence tomography: a comprehensive review clinical and research applications. JACC Cardiovasc Interv (2009) 2.64

Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J (2006) 2.23

Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging. JACC Cardiovasc Interv (2012) 2.05

In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation. JACC Cardiovasc Interv (2008) 1.91

Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol (2008) 1.84

Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: the LongOCT study (Optical Coherence Tomography in Long Lesions). JACC Cardiovasc Interv (2011) 1.52

Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging. JACC Cardiovasc Imaging (2012) 1.51

Reproducibility of qualitative assessment of stent struts coverage by optical coherence tomography. Int J Cardiovasc Imaging (2012) 1.43

Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv (2010) 1.38

Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. Circulation (2011) 1.31

Reproducibility of quantitative optical coherence tomography for stent analysis. EuroIntervention (2009) 1.17

Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model. Heart (2007) 1.12

Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur Heart J (2010) 1.01

Quantitative analysis of intracoronary optical coherence tomography measurements of stent strut apposition and tissue coverage. Int J Cardiol (2009) 0.95

Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI). Circ Cardiovasc Interv (2010) 0.90

Intriguing peri-strut low-intensity area detected by optical coherence tomography after coronary stent deployment. Circ J (2010) 0.89

Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study. JACC Cardiovasc Interv (2010) 0.88

Assessment of coronary stent by optical coherence tomography, methodology and definitions. Int J Cardiovasc Imaging (2011) 0.85

Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography. Circ Cardiovasc Interv (2012) 0.78

Will intravascular OCT shed light on vascular biology? JACC Cardiovasc Imaging (2010) 0.75

Articles by these authors

Consensus standards for acquisition, measurement, and reporting of intravascular optical coherence tomography studies: a report from the International Working Group for Intravascular Optical Coherence Tomography Standardization and Validation. J Am Coll Cardiol (2012) 4.29

Incremental value of adenosine-induced stress myocardial perfusion imaging with dual-source CT at cardiac CT angiography. Radiology (2010) 1.90

Intravascular optical coherence tomography detection of atherosclerosis and inflammation in murine aorta. Arterioscler Thromb Vasc Biol (2012) 1.61

Feasibility and safety of the second-generation, frequency domain optical coherence tomography (FD-OCT): a multicenter study. J Invasive Cardiol (2012) 1.47

Diagnostic accuracy of intravascular ultrasound-derived minimal lumen area compared with fractional flow reserve--meta-analysis: pooled accuracy of IVUS luminal area versus FFR. Catheter Cardiovasc Interv (2014) 1.42

Strategies for drug-eluting stent treatment of bifurcation coronary artery disease in the United States: insights from the e-Cypher S.T.L.L.R.trial. Catheter Cardiovasc Interv (2009) 1.41

Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. Eur Heart J (2012) 1.38

Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv (2010) 1.38

Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. Circulation (2011) 1.31

Volumetric quantification of fibrous caps using intravascular optical coherence tomography. Biomed Opt Express (2012) 1.15

Pericardial and thoracic peri-aortic adipose tissues contribute to systemic inflammation and calcified coronary atherosclerosis independent of body fat composition, anthropometric measures and traditional cardiovascular risks. Eur J Radiol (2011) 1.14

Use of 100 kV versus 120 kV in cardiac dual source computed tomography: effect on radiation dose and image quality. Int J Cardiovasc Imaging (2010) 1.11

The normal limits, subclinical significance, related metabolic derangements and distinct biological effects of body site-specific adiposity in relatively healthy population. PLoS One (2013) 1.06

Endovascular therapy for left main compression syndrome. Case report and literature review. Chest (2009) 1.03

In vitro validation of new Fourier-domain optical coherence tomography. EuroIntervention (2011) 1.00

Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses. Coron Artery Dis (2014) 0.99

Direct comparison of rest and adenosine stress myocardial perfusion CT with rest and stress SPECT. J Nucl Cardiol (2010) 0.97

Rationale and design of the HeartFlowNXT (HeartFlow analysis of coronary blood flow using CT angiography: NeXt sTeps) study. J Cardiovasc Comput Tomogr (2013) 0.94

Utilization of frequency domain optical coherence tomography and fractional flow reserve to assess intermediate coronary artery stenoses: conciliating anatomic and physiologic information. Int J Cardiovasc Imaging (2011) 0.94

Comparison between adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic plaques in human coronary arteries. Arq Bras Cardiol (2002) 0.92

Perivascular fat, inflammation, and cardiovascular risk in HIV-infected patients on antiretroviral therapy. Int J Cardiol (2013) 0.92

Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI). Circ Cardiovasc Interv (2010) 0.90

Optical coherence tomography (OCT) strut-level analysis of drug-eluting stents (DES) in human coronary bifurcations. EuroIntervention (2010) 0.90

Automatic stent detection in intravascular OCT images using bagged decision trees. Biomed Opt Express (2012) 0.89

Semiautomatic segmentation and quantification of calcified plaques in intracoronary optical coherence tomography images. J Biomed Opt (2011) 0.89

Plaque and thrombus evaluation by optical coherence tomography. Int J Cardiovasc Imaging (2011) 0.89

High pericardial and peri-aortic adipose tissue burden in pre-diabetic and diabetic subjects. BMC Cardiovasc Disord (2013) 0.87

Incidence, predictors, morphological characteristics, and clinical outcomes of stent edge dissections detected by optical coherence tomography. JACC Cardiovasc Interv (2013) 0.86

Impact of acute gain on clinical outcomes of patients treated with sirolimus-eluting stent. - A sub-analysis study from the STLLR trial-. Circ J (2011) 0.85

Vascular access in transcatheter aortic valve implantation. Int J Cardiovasc Imaging (2011) 0.85

Assessment of coronary artery calcium using dual-energy subtraction digital radiography. J Digit Imaging (2012) 0.85

Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: a study validated with computed tomography. J Am Soc Echocardiogr (2011) 0.84

[Use of optical coherence tomography for accurate characterization of atherosclerosis]. Arq Bras Cardiol (2010) 0.84

A role for archaeal organisms in development of atherosclerotic vulnerable plaques and myxoid matrices. Clinics (Sao Paulo) (2006) 0.83

Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial. Heart (2010) 0.82

Frequency-domain optical coherence tomography assessment of very late vascular response after carotid stent implantation. J Vasc Surg (2013) 0.81

Differences determined by optical coherence tomography volumetric analysis in non-culprit lesion morphology and inflammation in ST-segment elevation myocardial infarction and stable angina pectoris patients. Catheter Cardiovasc Interv (2014) 0.81

Serial Evaluation of Vascular Response After Implantation of a New Sirolimus-Eluting Stent With Bioabsorbable Polymer (MISTENT): an optical coherence tomography and histopathological study. J Invasive Cardiol (2012) 0.80

Impact of different stent alloys on human vascular response to everolimus-eluting stent: an optical coherence tomography study: the OCTEVEREST. Catheter Cardiovasc Interv (2012) 0.79

Volumetric characterization of human coronary calcification by frequency-domain optical coherence tomography. Circ J (2013) 0.79

Optical coherence tomography assessment of calcified plaque modification after rotational atherectomy. Catheter Cardiovasc Interv (2011) 0.79

Unrestricted utilization of frequency domain optical coherence tomography in coronary interventions. Int J Cardiovasc Imaging (2012) 0.79

Ex vivo cryoimaging for plaque characterization. JACC Cardiovasc Imaging (2014) 0.79

Volumetric assessment of lesion severity with optical coherence tomography: relationship with fractional flow. EuroIntervention (2013) 0.79

Frequency-domain optical coherence tomography assessment of unprotected left main coronary artery disease-a comparison with intravascular ultrasound. Catheter Cardiovasc Interv (2013) 0.78

Optical coherence tomography for characterization of cardiac allograft vasculopathy after heart transplantation (OCTCAV study). J Heart Lung Transplant (2013) 0.78

Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography. Circ Cardiovasc Interv (2012) 0.78

Serial assessment by optical coherence tomography of early and late vascular responses after implantation of an absorbable-coating Sirolimus-Eluting stent (from the first-in-human DESSOLVE I trial). Am J Cardiol (2013) 0.77

Coronary artery aneurysms after sirolimus-eluting stent implantation: multimodality imaging evaluation. JACC Cardiovasc Interv (2013) 0.76

Tuberculous pseudoaneurysms of the thoracic aorta: comprehensive evaluation by cardiovascular magnetic resonance. Circulation (2009) 0.76

Cardiovascular imaging 2011 in the International Journal of Cardiovascular Imaging. Int J Cardiovasc Imaging (2012) 0.75

Will intravascular OCT shed light on vascular biology? JACC Cardiovasc Imaging (2010) 0.75

An observational study of the association among interatrial adiposity by computed tomography measure, insulin resistance, and left atrial electromechanical disturbances in heart failure. Medicine (Baltimore) (2016) 0.75

"Old" problems revisited; imaging the coronary in high resolution. EuroIntervention (2009) 0.75

Novel use of optical coherence tomography. J Neurointerv Surg (2012) 0.75

Quantitative myocardial perfusion imaging in a porcine ischemia model using a prototype spectral detector CT system. Phys Med Biol (2016) 0.75

Fate of Nonculprit Plaques in Patients With STEMI Undergoing Primary PCI Followed by Statin Therapy: A Serial Optical Coherence Tomography Analysis From the OCTAVIA Study. JACC Cardiovasc Imaging (2016) 0.75

Images in cardiovascular medicine. The traveling amplatzer: rare complication of percutaneous atrial septal occluder device embolism. Circulation (2008) 0.75

Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography. JACC Cardiovasc Interv (2013) 0.75

Optical coherence tomography and intravascular ultrasound of double kissing crush coronary bifurcation stenting. EuroIntervention (2014) 0.75

Frequency-domain optical coherence tomography assessment of stent constriction 9 months after sirolimus-eluting stent implantation in a highly calcified plaque. JACC Cardiovasc Interv (2013) 0.75

Left ventricular restoration devices. J Cardiovasc Transl Res (2014) 0.75